logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Andrea Palloni

irccs azienda ospedaliero - universitaria di bologna
H指数:19
被引数:1,436

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score

预测阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者的失代偿：ARTE评分

Clinical Gastroenterology and Hepatology
IF12
2026-05-260
PRE
Lorenzo Canova; Eleonora Alimenti; Lorenzo Argiento; Giuseppe Cabibbo; Francesco Tovoli; Emanuela Di Giacomo; Peter R. Galle; Ciro Celsa; Matthias Pinter; Thomas U. Marron; Caterina Vivaldi; Andrea Dalbeni; Fabio Marra; Andrea Palloni; Sara Lonardi; Francesca Romana Ponziani; Piera Federico; Anwaar Saeed; Anjana Pillai; Tiziana Pressiani
Preliminary report on advanced biliary cancer patients receiving multimodality treatment in the immunotherapy era: a real-world multicentre experience

关于免疫治疗时代接受多模式治疗的晚期胆道癌患者的初步报告：一项真实世界多中心经验

Therapeutic Advances in Medical Oncology
IF4.2
2026-03-190
OA
Massimiliano Salati; Eleonora Borghi; Riccardo Cuoghi Costantini; Alessandro Parisi; Alessia Lancianese; Andrea Palloni; Chiara Ricci; Ingrid Garajova; Elena Orlandi; Ina Valeria Zurlo; Angelica Petrillo; Anna Diana; Angela Dalia Ricci; Alessandro Rizzo; Martina Manni; Ornella Garrone; Massimo Dominici; Michele Ghidini
Does Adjuvant Therapy in Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas Improve Survival? A Systematic Review and Meta-Analysis Using Trial Sequential Analysis

辅助治疗能否改善侵袭性胰导管内乳头状粘液性肿瘤的生存率？一项采用试验顺序分析的系统性评价和Meta分析

World Journal of Surgery
IF2.5
2025-12-010
OAAI
Ingaldi, Carlo; D'Ambra, Vincenzo; Ricci, Claudio; Alberici, Laura; Migliori, Marina; Di Marco, Mariacristina; Palloni, Andrea; Mosconi, Cristina; Serra, Carla; Casadei, Riccardo
Long-Term Outcomes and Prognostic Factors After Yttrium-90 Resin-Based Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Single-Center Experience

钇-90树脂基放射性栓塞术治疗不可切除性肝内胆管癌的长期疗效及预后因素：一项单中心经验

CardioVascular and Interventional Radiology
IF2.9
2025-11-050
PRE
Lorenzo Braccischi; Paolo Federico Garducci; Makoto Taninokuchi Tomassoni; Andrea Palloni; Sara Zanella; Giuseppe Della Gala; Lidia Strigari; Arber Golemi; Elisa Lodi Rizzini; Antonio De Cinque; Francesco Modestino; Giovanni Brandi; Cristina Mosconi
Efficacy and safety of atezolizumab/bevacizumab for hepatocellular carcinoma in a real-life prospective cohort: A 2024 update
DIGESTIVE AND LIVER DISEASE
IF3.8
2025-02-010
PRE
Stefanini, B.; Iavarone, M.; Marra, F.; Cabibbo, G.; Vivaldi, C.; Palloni, A.; Solda, C.; Ponziani, F. R.; Tesini, G.; Piscaglia, F.; Alimenti, E.; Campani, C.; Celsa, C.; Masi, G.; Brandi, G.; Lonardi, S.; Stella, L.; Pressiani, T.; Lani, L.; Dalbeni, A.; Svegliati-Baroni, G.; Federico, P.; Foschi, F. G.; De Lorenzo, S.; Tovoli, F.
Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma
DIGESTIVE AND LIVER DISEASE
IF3.8
2025-02-010
PRE
Ascari, S.; Chen, R.; Iavarone, M.; Stefanini, B.; Marra, F.; Cabibbo, G.; Vivaldi, C.; Palloni, A.; Solda, C.; Ponziani, F. R.; Valenzi, E.; Ravaioli, F.; Franceschini, E.; Tosetti, G.; Campani, C.; Celsa, C.; Masi, G.; Brandi, G.; Lonardi, S.; Stella, L.; Pressiani, T.; Lani, L.; Dalbeni, A.; Svegliati-Baroni, G.; Federico, P.; Ielasi, L.; De Lorenzo, S.; Piscaglia, F.; Tovoli, F.
Statins in patients with advanced hcc treated with atezolizumab/bevacizumab: a propensity score-matched cohort analysis from arte an Italian prospective multicentric dataset
DIGESTIVE AND LIVER DISEASE
IF3.8
2025-02-010
PRE
Dalbeni, A.; Cattazzo, F.; Auriemma, A.; Tovoli, F.; Iavarone, M.; Marra, F.; Cabibbo, G.; Vivaldi, C.; Palloni, A.; Solda, C.; Vicardi, M.; Natola, L. A.; Franceschini, E.; Bruccoleri, M.; Campani, C.; Celsa, C.; Masi, G.; Brandi, G.; Lonardi, S.; Ponziani, F. Romana; Rimassa, L.; Pressiani, T.; Stella, L.; Lani, L.; Svegliati-Baroni, G.; Federico, P.; Foschi, F.; De Lorenzo, S.; Sacerdoti, D.
The changing epidemiology of patients with HCC receiving a first-line systemic therapy: insights from ARPES and ARTE databases (2008-2024)
DIGESTIVE AND LIVER DISEASE
IF3.8
2025-02-010
PRE
Lani, L.; Piscaglia, F.; Zaccherini, G.; De Sinno, A.; Stefanini, B.; Iavarone, M.; Marra, F.; Cabibbo, G.; Vivaldi, C.; Palloni, A.; Solda, C.; Stella, L.; Bruccoleri, M.; Campani, C.; Celsa, C.; Masi, G.; Brandi, G.; Lonardi, S.; Ponziani, F. R.; Rimassa, L.; Pressiani, T.; Dalbeni, A.; Svegliati-Baroni, G.; Federico, P.; Ielasi, L.; De Lorenzo, S.; Caraceni, P.; Tovoli, F.
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma

索拉非尼作为阿特珠单抗-贝伐单抗治疗不可切除肝细胞癌的二线治疗的次优结果

DIGESTIVE AND LIVER DISEASE
IF3.8
2024-12-012
OAAI
Tovoli, Francesco; Pallotta, Dante Pio; Vivaldi, Caterina; Campani, Claudia; Federico, Piera; Palloni, Andrea; Dalbeni, Andrea; Solda, Caterina; Lani, Lorenzo; Svegliati-Baroni, Gianluca; Garajova, Ingrid; Ielasi, Luca; De Lorenzo, Stefania; Granito, Alessandro; Stefanini, Bernardo; Masi, Gianluca; Marra, Fabio; Lonardi, Sara; Brandi, Giovanni; Daniele, Bruno; Auriemma, Alessandra; Schiada, Laura; Chen, Rusi; Piscaglia, Fabio
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

Pemigatinib用于先前治疗过的局部晚期或转移性胆管癌患者的FGFR2融合或重排: 法国pemi-bil和意大利pemi-real队列研究的联合分析

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-03-015
OAAI
Parisi, Alessandro; Delaunay, Blandine; Pinterpe, Giada; Hollebecque, Antoine; Blanc, Jean Frederic; Bouattour, Mohamed; Assenat, Eric; Ben Abdelghani, Meher; Sarabi, Matthieu; Niger, Monica; Vivaldi, Caterina; Mandala, Mario; Palloni, Andrea; Bensi, Maria; Garattini, Silvio Ken; Tougeron, David; Combe, Pierre; Salati, Massimiliano; Rimini, Margherita; Cella, Chiara Alessandra; Tucci, Marco; Diana, Anna; Mori, Elena; Longarini, Raffaella; Artru, Pascal; Roth, Gael; Evesque, Ludovic; Vienne, Agathe; Turpin, Anthony; Hiret, Sandrine; Bourgeois, Vincent; Herve, Camille; Paulon, Rodolphe; Stacoffe, Marion; Malka, David; Neuzillet, Cindy; Edeline, Julien; Lievre, Astrid; Guimbaud, Rosine; Chapda, Marie Christelle Pajiep; Rimassa, Lorenza; Giampieri, Riccardo; Valle, Juan; Berardi, Rossana; Fares, Nadim
The synergic effect of metformin with atezolizumab/ bevacizumab in masld hcc patients: a retrospective study from arte multicentric Italian dataset
DIGESTIVE AND LIVER DISEASE
IF3.8
2024-02-010
PRE
Dalbeni, A.; Vicardi, M.; Natola, L. A.; Auriemma, A.; Stefanini, B.; Vivaldi, C.; Federico, P.; Palloni, A.; Solda, C.; Lani, L.; Garajova, I.; Tamberi, S.; De Lorenzo, S.; Piscaglia, F.; Milella, M.; Masi, G.; Lonardi, S.; Brandi, G.; Daniele, B.; Trevisani, F.; Svegliati-Baroni, G.; Marra, F.; Tovoli, F.; Sacerdoti, D.

研究方向

暂未获取到该数据
G
Giovanni Brandi
H 指数:65论文数:496被引数:1.7万
G
Giorgio Frega
H 指数:18论文数:104被引数:1,437
S
Stefania De Lorenzo
H 指数:19论文数:104被引数:1,374
A
Alessandro Rizzo
H 指数:67论文数:327被引数:1.0万
S
Simona Tavolari
H 指数:29论文数:118被引数:4,566
I
Ingrid Garajová
H 指数:24论文数:215被引数:1,854
C
Caterina Vivaldi
H 指数:32论文数:334被引数:3,669
F
Francesco Tovoli
H 指数:40论文数:257被引数:7,052
A
Angela Dalia Ricci
H 指数:37论文数:202被引数:4,397
A
Andrea Dalbeni
H 指数:25论文数:212被引数:3,047